Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: A subgroup with an aggressive disease course

Annals of Hematology

Volumn 91, Issue 6, 2012, Pages 863-873

  Put, Natalie ^a   Van Roosbroeck, Katrien ^a   Konings, Peter ^b   Meeus, Peter ^a,c   Brusselmans, Caroline ^d   Rack, Katrina ^e   Gervais, Carine ^f   Nguyen Khac, Florence ^g,h   Chapiro, Elise ^g,h   Radford Weiss, Isabelle ⁱ   Struski, Stéphanie ^j   Dastugue, Nicole ^j   Gachard, Nathalie ^k   Lefebvre, Christine ^l   Barin, Carole ^m   Eclache, Virginie ⁿ   Fert Ferrer, Sandra ^o   Laibe, Sophy ^p   Mozziconacci, Marie Joëlle ^p   Quilichini, Benoît ^q   Poirel, Hélène A ^r   Wlodarska, Iwona ^a   Hagemeijer, Anne ^a   Moreau, Yves ^b   Vandenberghe, Peter ^a   Michaux, Lucienne ^a,s   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Katholieke Universiteit Leuven   (Belgium)

^c OLV HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h CENTRE DE RECHERCHE DES CORDELIERS   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j TOULOUSE UNIVERSITY HOSPITAL   (France)

^k LIMOGES UNIVERSITY HOSPITAL   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

^m UNIVERSITY HOSPITAL OF TOURS   (France)

ⁿ AVICENNE HOSPITAL   (France)

^o Hôpital de Chambéry   (France)

^p INSTITUT PAOLI CALMETTES   (France)

^q Laboratoire Biomnis   (France)

^r UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^s CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

more..

Author keywords

Burkitt; Chronic lymphocytic leukemia; MYC; Prognosis; t(8; 14); Translocation

Indexed keywords

ALEMTUZUMAB; CD23 ANTIGEN; CD5 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG RESPONSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; KARYOTYPE; LEUKEMOGENESIS; MALE; MALIGNANT TRANSFORMATION; MONOSOMY; ONCOGENE MYC; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROLYMPHOCYTIC LEUKEMIA; SEX DIFFERENCE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENES, MYC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, PROLYMPHOCYTIC; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 84862651952     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1393-y     Document Type: Article

References (38)

1. Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G, Dohner H, Hallek M, Hillmen P, Keating M, Montserrat E, Kipps TJ, Rai K (2006) Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 107:859-861 (Pubitemid 43156279)
2. Van Den Neste E, Robin V, Francart J, Hagemeijer A, Stul M, Vandenberghe P, Delannoy A, Sonet A, Deneys V, Costantini S, Ferrant A, Robert A, Michaux L (2007) Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine. Leukemia 21:1715-1722 (Pubitemid 47086762)
3. Dicker F, Schnittger S, Haferlach T, Kern W, Schoch C (2006) Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood 108:3152-3160
4. Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner CM (2006) Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107:742-751 (Pubitemid 43076401)
5. Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 28:3360-3365
6. Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C, Leyvraz S, Michallet M, Yakoub-Agha I, Garderet L, Marit G, Michaux L, Voillat L, Renaud M, Grosbois B, Guillerm G, Benboubker L, Monconduit M, Thieblemont C, Casassus P, Caillot D, Stoppa AM, Sotto JJ, Wetterwald M, Dumontet C, Fuzibet JG, Azais I, Dorvaux V, Zandecki M, Bataille R, Minvielle S, Harousseau JL, Facon T, Mathiot C (2007) Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 109:3489-3495 (Pubitemid 46572539)
7. Obermann EC, Csato M, Dirnhofer S, Tzankov A (2009) Aberrations of theMYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment. J Clin Pathol 62:754-756
8. Huh YO, Lin KI, Vega F, Schlette E, Yin CC, Keating MJ, Luthra R, Medeiros LJ, Abruzzo LV (2008) MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol 142:36-44 (Pubitemid 351783149)
9. Mitelman F, Johansson B, Mertens F (eds) (2010) Mitelman database of chromosome aberrations and gene fusions in cancer. http://cgap.nci.nih.gov/ Chromosomes/Mitelman
10. Klapproth K, Wirth T (2010) Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 149:484-497
11. Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel MN, Ruminy P, Picquenot JM, Tilly H (2007) Mapping of MYC breakpoints in 8q24 rearrangements involving nonimmunoglobulin partners in B-cell lymphomas. Leukemia 21:515-523
12. Nowakowski GS, Dewald GW, Hoyer JD, Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED, Phyliky RL, Call TG, Shanafelt TD, Kay NE, Zent CS (2005) Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 130:36-42 (Pubitemid 40979130)
13. Cavazzini F, Hernandez JA, Gozzetti A, Russo Rossi A, De Angeli C, Tiseo R, Bardi A, Tammiso E, Crupi R, Lenoci MP, Forconi F, Lauria F, Marasca R, Maffei R, Torelli G, Gonzalez M, Martin-Jimenez P, Maria Hernandez J, Rigolin GM, Cuneo A (2008) Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. Br J Haematol 142:529-537 (Pubitemid 352020210)
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 42:567-584 (Pubitemid 19156426)
15. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640-1645 (Pubitemid 24323778)
16. Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D (1997) Improvement of the chronic lymphocytic leukemia scoring system with themonoclonal antibody SN8 (CD79b). Am J Clin Pathol 108: 378-382 (Pubitemid 27411287)
17. Put N, Konings P, Rack K, Jamar M, Van Roy N, Libouton JM, Vannuffel P, Sartenaer D, Ameye G, Speleman F, Herens C, Poirel HA, Moreau Y, Hagemeijer A, Vandenberghe P, Michaux L (2009) Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study. Genes Chromosom Cancer 48:843-853
18. Brochet X, Lefranc MP, Giudicelli V (2008) IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36:W503-W508
19. Henglein B, Synovzik H, Groitl P, Bornkamm GW, Hartl P, Lipp M (1989) Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol Cell Biol 9:2105-2113 (Pubitemid 19117811)
20. R Development Core Team (2010) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
21. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87:4990-4997 (Pubitemid 26189840)
22. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446-5456
23. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S, Elonen E, Gahrton G (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720-724 (Pubitemid 20288941)
24. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T (2007) Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21:2442-2451 (Pubitemid 350148886)
25. Nowakowski GS, Smoley S, Schwager S, Zent CS, Call TG, Shanafelt TD, Hanson CA, Tschumper RC, Jelinek DF, Van Dyke DL, Kay NE (2007) Presence of immunoglobulin heavy chain gene (IGH) translocations in chronic lymphocytic leukemia is related to poor prognosis. ASH Annual Meeting Abstracts, vol 110, p. 2067
26. Martin-Subero JI, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz MJ, De Wolf-Peeters C, Dyer MJ, Felman P, Gardiner A, Gascoyne RD, Gesk S, Harder L, Horsman DE, Kneba M, Kuppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Sole F, Thiel G, Wacker HH, Oscier D, Wlodarska I, Siebert R (2007) A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia 21:1532-1544 (Pubitemid 46969871)
27. Chapiro E, Radford-Weiss I, Bastard C, Luquet I, Lefebvre C, Callet-Bauchu E, Leroux D, Talmant P, Mozziconacci MJ, Mugneret F, Struski S, Raynaud S, Andrieux J, Barin C, Jotterand M, Mossafa H, Ramond S, Terre C, Lippert E, Berger F, Felman P, Merle-Beral H, Bernard OA, Davi F, Berger R, Nguyen-Khac F (2008) The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia. Leukemia 22:2123-2127
28. Put N, Meeus P, Chatelain B, Rack K, Boeckx N, Nollet F, Graux C, Van Den Neste E, Janssens A, Madoe V, Van Hoof A, Bilhou-Nabera C, Wlodarska I, Vandenberghe P, Michaux L (2009) Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia. Leukemia 23:1201-1204
29. Delgado M, León J (2010) Myc roles in hematopoiesis and leukemia. Genes & Cancer 1:605-616
30. Zhang W, Kater AP, Widhopf GF 2nd, Chuang HY, Enzler T, James DF, Poustovoitov M, Tseng PH, Janz S, Hoh C, Herschman H, Karin M, Kipps TJ (2010) B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 107:18956-18960
31. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL (2004) The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl) 13:279-287 (Pubitemid 38834460)
32. Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ (2003) Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 127:305-309 (Pubitemid 36378693)
33. Kroft SH, Dawson DB, McKenna RW (2001) Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases. Am J Clin Pathol 115:385-395 (Pubitemid 33694836)
34. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916 (Pubitemid 32064784)
35. Lau LC, Lim P, Lim YC, Teng LM, Lim TH, Lim LC, Tan SY, Lim ST, Sanger WG, Tien SL (2008) Occurrence of trisomy 12, t(14;18) (q32;q21), and t(8;14)(q24. 1;q11. 2) in a patient with B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 185:95-101
36. Lens D, Coignet LJ, Brito-Babapulle V, Lima CS, Matutes E, Dyer MJ, Catovsky D (1999) B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene. Leukemia 13:873-876 (Pubitemid 29292137)
37. Maclean KH, Kastan MB, Cleveland JL (2007) Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis. Mol Cancer Res 5:705-711 (Pubitemid 47105489)
38. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13:2658-2669 (Pubitemid 29508553)